The present study shows that combination of AEE788 with the specific COX-2 inhibitor celecoxib not only demonstrated enhanced anti-tumoral efficacy in colorectal cancer cells but also reduced colon CSCs subpopulation by targeting stemness-related pathways. This evidence concerns the gene PTGS2 and colorectal cancer.